Other
Female Infertility
19
Pipeline Programs↗
3
Active Trials↗
9
Companies Involved↗
Female Infertility is an emerging landscape with 19 programs across 9 companies. The most active players are Merck & Co., Solvay Pharmaceuticals, Arbor Pharmaceuticals, Inc.. 6 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical7
Phase 11
Phase 24
Analysis
Trial Status
5
clinical trials
Completed2 · 40%
Recruiting2 · 40%
Not yet recruiting1 · 20%
Clinical Trials
Trial Activity
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)